Related Experiment Video
Updated: May 5, 2026
Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
Published on: April 19, 2017
Clinical Trials for Developing Treatment and Early Diagnostic Methods for Chronic Active Antibody-Mediated Rejection
1Department of Renal and Genitourinary Surgery, Faculty of Medicine, Hokkaido University, Sapporo, Japan, hotta1125@mac.com.
Background:
Development of immunosuppressants has reduced the incidence of acute T-cell-mediated rejection (TCMR) and significantly improved the short-term outcome of kidney transplantation. However, in the long term, many cases of transplanted kidney failure are due to chronic active antibody-mediated rejection (CAAMR) caused by donor-specific antibodies. Overcoming this is essential for improving long-term outcomes. The mechanism of CAAMR remains largely unknown and no effective treatment is currently available.
Summary:
Various therapeutic approaches have been attempted for cases that have progressed to CAAMR. However, an effective treatment method has yet to be established. Therefore, efforts are underway to develop diagnostic methods for identifying patients at risk of developing CAAMR either before its occurrence or as early as possible. Recent reports have identified potential biomarkers in the urine and blood for the early diagnosis of CAAMR. In addition, the molecular analyses of kidney allograft biopsy tissues are being explored for early diagnostic methods. This review summarizes the current treatments for CAAMR and the trials aimed at developing early-stage diagnostic methods for detecting CAAMR.
Key Messages:
Various new diagnostic methods have successively attempted to replace histological examination in the diagnosis of kidney transplant rejection; most have focused on TCMR or acute antibody-mediated rejection. The development of early diagnostic methods for CAAMR is still in its infancy and future advancements are anticipated.
Insights
Chronic active antibody-mediated rejection (CAAMR) remains a major cause of long-term kidney transplant failure. Current treatments are limited, driving research into early diagnostic methods for CAAMR.
Area of Science:
- Nephrology
- Transplantation Immunology
- Diagnostic Biomarkers
Background:
- Immunosuppressants improve short-term kidney transplant outcomes by reducing acute rejection.
- Long-term kidney transplant failure is often caused by chronic active antibody-mediated rejection (CAAMR).
- The mechanisms and effective treatments for CAAMR are not well understood.
Purpose of the Study:
- To review current therapeutic strategies for established CAAMR.
- To summarize ongoing efforts in developing early diagnostic methods for CAAMR.
- To highlight the need for improved diagnostics to identify at-risk patients.
Main Methods:
- Review of current literature on CAAMR treatments.
- Analysis of emerging diagnostic approaches, including biomarkers and molecular tissue analysis.
- Synthesis of findings related to early detection of CAAMR.
Main Results:
- Established treatments for CAAMR have not yet proven effective.
- Potential biomarkers in urine and blood show promise for early CAAMR diagnosis.
- Molecular analysis of kidney allograft biopsies is being explored for diagnostic potential.
Conclusions:
- Effective treatments for advanced CAAMR are still lacking.
- Early diagnostic methods for CAAMR are crucial for improving long-term transplant survival.
- While diagnostic advancements are emerging, early CAAMR detection remains a developing field.
Related Concept Videos
01:28Kidney Transplant I: Introduction
01:26Kidney Transplant II: Surgical Procedure
01:16Kidney Transplant III: Nursing Management
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:25Chronic Kidney Disease I: Introduction
01:28Chronic Kidney Disease III: Interprofessional Care